Yield10 Bioscience logo

Yield10 Bioscience(OTC) YTEN

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2006)-100%
5 Year-100%
1 Year-99%
1 Month-99%
N/A
Yield10 Bioscience last closing stock price
MetricPriceDate
Last closeUSD 0.002026-10-07
Yield10 Bioscience stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-09-25
1 month-99%USD 0.002026-09-04
3 month+0%USD 0.002026-07-06
Year to date+0%USD 0.002025-12-31
1 year-99%USD 0.002025-10-01
3 year-100%USD 7.562023-10-06
5 year-100%USD 138.722021-10-08
Since inception-100%USD 893,952.572006-11-10

Yield10 Bioscience Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$810.00K

Net Income (TTM)

-$12.70M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Dec 16, 2024

YTEN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Yield10 Bioscience

Yield10 Bioscience, Inc. is an agricultural biotechnology firm focused on enhancing crop productivity through innovative solutions. The company utilizes its proprietary Trait Factory gene discovery platform to develop advanced oilseed varieties, particularly Camelina sativa, and collaborates with key industry players.

Products and Services
  • Advanced oilseed varieties for agricultural applications
  • Proprietary Trait Factory gene discovery platform
  • Licensing agreements with major industry partners
Growth Outlook
  • Recent quarterly revenue increased to $450,000, up from $300,000
  • Partnerships with industry leaders like Bayer AG enhance market reach
  • Focus on innovative crop solutions aligns with growing agricultural demands
Financial Highlights
  • Trailing twelve months revenue of $1.35 million
  • Net income for Q2 2024 reported at -$3.24 million
  • Cash and cash equivalents at $733,000 as of June 30, 2024
Yield10 Bioscience, Inc. operates in the agricultural inputs sector, aiming to address the increasing global demand for sustainable crop solutions. The company's innovative approach, particularly through its Trait Factory platform, positions it well within the biotechnology landscape. Recent financial performance indicates a growing revenue trend, with a notable increase in quarterly revenue, reflecting the potential for future growth. Partnerships with established industry players further enhance the company's market presence and credibility. Despite current net losses, the focus on research and development may lead to significant advancements in crop productivity, aligning with broader agricultural trends. Investors may find interest in the company's strategic direction and its commitment to innovation in the agricultural biotechnology field.
AI Generated • Oct 13, 2026

Industry

Biotechnology

Employees

29

CEO

Oliver P. Peoples, PhD

Headquarters

Woburn, MA 01801, US

YTEN Financials

Key Financial Metrics (TTM)

Gross Margin

-383.33%

Operating Margin

-24028.33%

Net Income Margin

-24091.67%

Return on Equity

-1508.09%

Return on Capital

-1996.81%

Return on Assets

-369.98%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$665.00K

Operating Income

-$12.59M

EBITDA

-$12.32M

Operating Cash Flow

-$5.80M

Capital Expenditure

-$19.00K

Free Cash Flow

-$5.82M

Cash & ST Invst.

$733.00K

Total Debt

$2.79M

Yield10 Bioscience Performance Analysis

Yield10 Bioscience annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 614,000N/A
20222022-12-31USD 450,000-26.7%
20232023-12-31USD 60,000-86.7%
Yield10 Bioscience sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32023-09-30N/A
Q42023-12-31N/A
Q12024-03-31400.0%
Q22024-06-3050.0%
Yield10 Bioscience annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -55.95N/A
20222022-12-31USD -66.2518.4%
20232023-12-31USD -43.66-34.1%
Yield10 Bioscience sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32023-09-3035.5%
Q42023-12-3134.3%
Q12024-03-3127.1%
Q22024-06-30-5.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2024YOY CHG

Revenue

$450.00K

N/A

Gross Profit

$450.00K

+648.8%

Gross Margin

100.00%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

29

N/A

Net Income

-$3.24M

+12.0%

EBITDA

-$3.14M

+12.5%

Quarterly Fundamentals

Name
Q2 2024YOY CHG

Total Cash

$733.00K

-68.6%

Total Debt

$2.79M

-20.3%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$1.09M

-61.4%

Short Term Debt

$1.70M

+148.0%

Return on Assets

-3.70%

N/A

Return on Invested Capital

15.05%

N/A

Free Cash Flow

-$574.00K

+81.5%

Operating Cash Flow

-$574.00K

+81.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
KPLUYK+S AG
$7.90-0.38%
IPIIntrepid Potash, Inc.
$32.17+1.30%
BIOXBioceres Crop Solutions Corp.
$0.30-0.03%
VNPKFVerde AgriTech Ltd
$0.60+3.45%

Trending Stocks

Symbol / CompanyPricePrice Chg
CCCCCC Intelligent Solutions
$7.64-2.30%
KORUDirexion Shares ETF Trust - Direxion Daily Msci South Korea Bull 3x Shares
$12.93-12.16%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$110.54-13.35%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$42.52+13.63%

Questions About YTEN

What is the current price of Yield10 Bioscience?

Yield10 Bioscience is trading at N/A per share.

What is the 52-week range for Yield10 Bioscience?

Over the past 52 weeks, Yield10 Bioscience has traded between N/A and N/A.

How much debt does Yield10 Bioscience have?

As of the most recent reporting period, Yield10 Bioscience reported total debt of $3.18M.

How much cash does Yield10 Bioscience have on hand?

Yield10 Bioscience reported $1.07M in cash and cash equivalents in its most recent financial results.

What is Yield10 Bioscience’s dividend yield?

Yield10 Bioscience does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.